Figure 1.
![Clinical features of patients. (A-F) Inflammatory skin manifestations of patients. (A-B) Inflammatory skin rash in patient 5 at the onset of systemic inflammatory symptoms at 4 weeks of life (pre-HSCT). (C) Cellulitis-like lesions of the third finger in patient 8 (pre–gene therapy [GT]). (D) Vasculitic lesions of the trunk and the extremities in patient 1 at 2.5 months of age (pre-HSCT). (E) Pyoderma gangrenosum in patient 4 (pre-HSCT). (F) Vasculitis-like lesions of the foot in patient 2 (post-HSCT; see also panel G). (G) Post-HSCT donor chimerism and time course of inflammatory manifestations in patient 2.](https://ash.silverchair-cdn.com/ash/content_public/journal/blood/144/16/10.1182_blood.2024024524/3/blood_bld-2024-024524-gr1.jpeg?Expires=1765349113&Signature=RrvIAOLsga8cRK8~ntQgo0YjuhLI17MhP1rOmgF4RY~r95OnRze4Py-HoRbIdhWk8f47AxqNH66q8Ld8VXE2~76zvOfF2sGVj1ID7Etq66hRbFvC5oZiE6K7VwOTcuifEZ4Rqvid4WpSm3gHcAykoGw6wDvjsMonDozTHK9rU5xN4KpFkFrR0EhgzlqecWiDuxCEJ9NmlgDu7-mHMX9rVVof8~5h8CiInApbiTk~QeHFFRBFnpBc8FZ2jmB5ruxXlDJXfIZFbu~52XjRiIzI5X~zO1PADZPNKGDRb05oDfgWrpCQ9BnQ8TkaBrxFiYfYQ6EE0NycvkjagD0OZiNMfw__&Key-Pair-Id=APKAIE5G5CRDK6RD3PGA)
Clinical features of patients. (A-F) Inflammatory skin manifestations of patients. (A-B) Inflammatory skin rash in patient 5 at the onset of systemic inflammatory symptoms at 4 weeks of life (pre-HSCT). (C) Cellulitis-like lesions of the third finger in patient 8 (pre–gene therapy [GT]). (D) Vasculitic lesions of the trunk and the extremities in patient 1 at 2.5 months of age (pre-HSCT). (E) Pyoderma gangrenosum in patient 4 (pre-HSCT). (F) Vasculitis-like lesions of the foot in patient 2 (post-HSCT; see also panel G). (G) Post-HSCT donor chimerism and time course of inflammatory manifestations in patient 2.
